Ten years of biosimilars in Europe: development and evolution of the regulatory pathways
August 1, 2018Comments Off on Ten years of biosimilars in Europe: development and evolution of the regulatory pathways Posted in: Insights
This paper was originally published by Martin Schiestl, Markus Zabransky, and Fritz Sörgel in Drug Des Devel Ther. 2017; 11: 1509–1515 under a Creative Commons Attribution – Non Commercial (unported, v3.0) License. Abstract…
The post Ten years of biosimilars in Europe: development and evolution of the regulatory pathways appeared first on DrugPatentWatch - Make Better Decisions.